Sonic Healthcare Limited (SHL.AX,SKHCF.PK), an Australian provider of laboratory, pathology, and radiology services, reported that its net profit for the half year ended 31 December 2024 increased to A$237 million from A$202 million in the prior year.
Revenue for the period grew to A$4.669 billion from A$4.306 billion in the prior year.
The company has maintained its progressive dividend policy, announcing an increase of 1 cent (2.3%) to 44 cents per share for the 2025 interim dividend.
The company stated that it is on track to achieve its full-year 2025 EBITDA guidance, projected to be in the range of A$1.70 billion - A$1.75 billion on a constant currency basis.
Looking ahead, the company expects ongoing earnings growth driven by strong organic revenue growth and consequent operational leverage, and enhanced by specific factors including the realization of synergies from recent acquisitions.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.